|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02185 BIOHEART-B
Nominal 
7.420 +0.150 (+2.063%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 20,862 | -- | 0 | 0 | 0 | 0 |
| Cost of Sales | (11,167) | -- | -- | -- | -- | -- |
| Gross Profit | 9,695 | -- | -- | -- | -- | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (256) | -61.271% | (986) | (1,633) | (1,430) | 0 | |
| Profit / (Loss) before Taxation | (27,420) | -3.195% | (93,324) | (188,820) | (230,868) | (409,825) | |
| Taxation | 686 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (479) | -- | 5,380 | 12,927 | 26,632 | 48,376 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (27,213) | 5.354% | (87,944) | (175,893) | (204,236) | (361,449) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,915 | -- | (1,042) | (3,422) | (3,051) | (287) |
| Depreciation & Amortisation | 7,772 | 93.622% | 8,174 | 21,355 | 20,857 | 13,234 |
| Directors' Emoluments | -- | -- | 3,575 | 39,255 | 104,729 | 220,690 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -11.000 | 0.000% | -36.000 | -72.000 | -84.000 | -164.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.491) | (0.201) | (0.577) | (0.401) |
| NBV per share ($) | 1.958 | -- | 2.708 | 3.068 | 3.621 | 4.082 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -27,213 |
| %Change | 5.354% |
| EPS / (LPS) | RMB -0.110 |
| NBV Per Share (¥) | RMB 1.958 |